Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122390078 | 12239007 | 8 | F | 2016 | 20160907 | 20160405 | 20160914 | PER | US-PFIZER INC-2016105397 | PFIZER | 73.00 | YR | M | Y | 57.14000 | KG | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122390078 | 12239007 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, 1X/DAY | Y | 21938 | 37.5 | MG | CAPSULE, HARD | QD | |||||
| 122390078 | 12239007 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, 1X/DAY | Y | 21938 | 37.5 | MG | CAPSULE, HARD | QD | |||||
| 122390078 | 12239007 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, 1X/DAY (1 CAPSULE (12.5 MG) FOR 28 DAYS, TAKE WITH 25 MG CAPSULE; TOTAL 37.5 MG DAILY) | Y | 21938 | 37.5 | MG | CAPSULE, HARD | QD | |||||
| 122390078 | 12239007 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, 1X/DAY | Y | 21938 | 37.5 | MG | CAPSULE, HARD | QD | ||||||
| 122390078 | 12239007 | 5 | C | DOCQLACE | DOCUSATE SODIUM | 1 | UNK | 0 | |||||||||||
| 122390078 | 12239007 | 6 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 122390078 | 12239007 | 7 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | UNK | 0 | |||||||||||
| 122390078 | 12239007 | 8 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122390078 | 12239007 | 1 | Gastrointestinal stromal tumour |
| 122390078 | 12239007 | 2 | Synovial sarcoma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122390078 | 12239007 | Contusion | |
| 122390078 | 12239007 | Diarrhoea | |
| 122390078 | 12239007 | Dry mouth | |
| 122390078 | 12239007 | Dry skin | |
| 122390078 | 12239007 | Fatigue | |
| 122390078 | 12239007 | Palmar-plantar erythrodysaesthesia syndrome | |
| 122390078 | 12239007 | Product use issue | |
| 122390078 | 12239007 | Rash | |
| 122390078 | 12239007 | Skin exfoliation | |
| 122390078 | 12239007 | Weight decreased | |
| 122390078 | 12239007 | Yellow skin |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122390078 | 12239007 | 1 | 20160201 | 0 | ||
| 122390078 | 12239007 | 2 | 20160310 | 0 | ||
| 122390078 | 12239007 | 3 | 20160610 | 0 | ||
| 122390078 | 12239007 | 4 | 201603 | 20160801 | 0 | |
| 122390078 | 12239007 | 5 | 20160817 | 0 | ||
| 122390078 | 12239007 | 6 | 20160818 | 0 | ||
| 122390078 | 12239007 | 7 | 20160201 | 20160301 | 0 | |
| 122390078 | 12239007 | 8 | 20160301 | 0 |